These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3855324)

  • 1. An in vivo model for squamous cell carcinoma of the head and neck.
    Baker SR
    Laryngoscope; 1985 Jan; 95(1):43-56. PubMed ID: 3855324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the head and neck heterotransplanted to nude mice. Take rate in relation to patient survival.
    Zätterström UK; Wennerberg J; Attewell R; Ask A
    Cancer; 1990 Jul; 66(1):145-51. PubMed ID: 2354400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
    Heo DS; Snyderman C; Gollin SM; Pan S; Walker E; Deka R; Barnes EL; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1989 Sep; 49(18):5167-75. PubMed ID: 2766286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.
    Rheinwald JG; Beckett MA
    Cancer Res; 1981 May; 41(5):1657-63. PubMed ID: 7214336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in growth pattern of human squamous-cell carcinomas of the head and neck during serial passages in nude mice.
    Wennerberg J
    Int J Cancer; 1984 Feb; 33(2):245-50. PubMed ID: 6693202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
    Wennerberg J; Alm P; Lögdberg L; Tropé C
    Acta Otolaryngol; 1984; 98(3-4):335-42. PubMed ID: 6388230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological characteristics predictive for growth of squamous cell carcinomas of the head and neck heterotransplanted to nude mice.
    Wennerberg J; Willén R; Biörklund A; Tropé C
    Anticancer Res; 1986; 6(5):1165-70. PubMed ID: 3800324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.
    Perez-Soler R; Kemp B; Wu QP; Mao L; Gomez J; Zeleniuch-Jacquotte A; Yee H; Lee JS; Jagirdar J; Ling YH
    Clin Cancer Res; 2000 Dec; 6(12):4932-8. PubMed ID: 11156254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nude mouse xenograft system: a model for photodetection and photodynamic therapy in head and neck squamous cell carcinoma.
    Hill JH; Plant RL; Harris DM; Grossweiner LI; Rok B; Seter AJ
    Am J Otolaryngol; 1986; 7(1):17-27. PubMed ID: 3953966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biologic characteristics of seven new cell lines of squamous cell carcinomas of the head and neck and comparison to fresh tumor tissue.
    Welkoborsky HJ; Jacob R; Riazimand SH; Bernauer HS; Mann WJ
    Oncology; 2003; 65(1):60-71. PubMed ID: 12837984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.
    Rudy SF; Brenner JC; Harris JL; Liu J; Che J; Scott MV; Owen JH; Komarck CM; Graham MP; Bellile EL; Bradford CR; Prince ME; Carey TE
    J Otolaryngol Head Neck Surg; 2016 Apr; 45():26. PubMed ID: 27117272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
    Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
    Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
    Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of proliferation kinetics in human squamous cell carcinomas of the head and neck.
    Harari PM; Contreras L; Pickart MA; Ritter MA; Kinsella TJ
    Arch Otolaryngol Head Neck Surg; 1993 Jul; 119(7):738-42. PubMed ID: 8318203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-in-mouse modeling of primary head and neck squamous cell carcinoma.
    Law JH; Whigham AS; Wirth PS; Liu D; Pham MQ; Vadivelu S; Kirkbride KC; Brown BT; Burkey BB; Sinard RJ; Netterville JL; Yarbrough WG
    Laryngoscope; 2009 Dec; 119(12):2315-23. PubMed ID: 19693929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors: strategies for improved locoregional control.
    Petereit DG; Harari PM; Contreras L; Pickart MA; Verma AK; Gerner EW; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):891-8. PubMed ID: 8138442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA--cytometric studies on xenografts of squamous cell carcinomas of the head and neck.
    Elprana D; Kuijpers W; Peperkamp AR; Wagener DJ
    Anticancer Res; 1991; 11(5):1943-9. PubMed ID: 1768066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper aerodigestive neoplasm perpetuated in the nude mouse.
    Fantozzi R; Bone R; Fernsten P; Walker L
    Laryngoscope; 1986 Jun; 96(6):621-4. PubMed ID: 3713405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of single agent oral fusaric acid (FA) on the growth of subcutaneously xenografted SCC-1 cells in a nude mouse model.
    Ruda JM; Beus KS; Hollenbeak CS; Wilson RP; Stack BC
    Invest New Drugs; 2006 Sep; 24(5):377-81. PubMed ID: 16505952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.